On Tuesday, Apogee Therapeutics Inc (NASDAQ: APGE) opened higher 10.89% from the last session, before settling in for the closing price of $56.77. Price fluctuations for APGE have ranged from $26.20 to $63.50 over the past 52 weeks.
Company’s average yearly earnings per share was noted -27.30% at the time writing. With a float of $39.57 million, this company’s outstanding shares have now reached $59.32 million.
Apogee Therapeutics Inc (APGE) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Apogee Therapeutics Inc is 33.60%, while institutional ownership is 83.48%. The most recent insider transaction that took place on Nov 05 ’25, was worth 593,903. In this transaction Chief Medical Officer of this company sold 10,785 shares at a rate of $55.07, taking the stock ownership to the 282,008 shares. Before that another transaction happened on Nov 05 ’25, when Company’s Officer proposed sale 10,785 for $53.90, making the entire transaction worth $581,312.
Apogee Therapeutics Inc (APGE) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -1.2 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -1.07) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -27.30% per share during the next fiscal year.
Apogee Therapeutics Inc (NASDAQ: APGE) Trading Performance Indicators
Check out the current performance indicators for Apogee Therapeutics Inc (APGE). In the past quarter, the stock posted a quick ratio of 15.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.32, a number that is poised to hit -1.10 in the next quarter and is forecasted to reach -4.78 in one year’s time.
Technical Analysis of Apogee Therapeutics Inc (APGE)
Analysing the last 5-days average volume posted by the [Apogee Therapeutics Inc, APGE], we can find that recorded value of 0.85 million was better than the volume posted last year of 0.73 million. As of the previous 9 days, the stock’s Stochastic %D was 68.41%.
During the past 100 days, Apogee Therapeutics Inc’s (APGE) raw stochastic average was set at 96.98%, which indicates a significant increase from 92.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.15 in the past 14 days, which was higher than the 2.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $46.55, while its 200-day Moving Average is $40.08. Now, the first resistance to watch is $65.69. This is followed by the second major resistance level at $68.42. The third major resistance level sits at $73.01. If the price goes on to break the first support level at $58.37, it is likely to go to the next support level at $53.78. Now, if the price goes above the second support level, the third support stands at $51.05.
Apogee Therapeutics Inc (NASDAQ: APGE) Key Stats
There are currently 46,110K shares outstanding in the company with a market cap of 4.30 billion. Presently, the company’s annual sales total 0 K according to its annual income of -182,150 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -66,100 K.
